|
IRWD | Ironwood Pharmaceuticals Inc |
|
|
IRWD | Ironwood Pharmaceuticals Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -1.01 |
| Leverage | 160.31% |
| Market Cap | $ 731.0m |
| PE | 7.18 |
| Dividend Yield | 0.00% |
| Profit | $ 101.7m |
| Margin | 28.74% |
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.